Nippon India Pharma Fund - Direct Plan - Bonus Plan
3Y Annualised
21.12%
-0.66% 1D
Fund Performance
Fund Multiplier
Fund Info
Peer Comparison
Fund Managers
AMC Details
Performance
1M Returns
3.56%
-0.66% 1D
Benchmark
N/A
Fund Multiplier
Time it would have taken to make your money double (2x), quadruple (4x) and quintuple (5x)
3 years 7 months
5 years 5 months
9 years 7 months
Fund info
Fund size
₹8080.97 Cr
Min. SIP amount
₹100
Min. Lumpsum amount
₹5000
Exit load
0.01%
1% if redeemed or switched out on or before completion of 1 month from the date of allotment of units. Nil, thereafter.
Risk Profile
Very High Risk
This Fund's Performance Compared With Peers
Over the Period of oneMonth
Fund Managers
About Nippon India Pharma Fund - Direct Plan - Bonus Plan
Nippon India Pharma Fund - Direct Plan - Bonus Plan is a Equity mutual fund scheme from Nippon Life India Asset Management Ltd. This fund has been in existence for 12 years, having been launched on 2013-01-01. Nippon India Pharma Fund - Direct Plan - Bonus Plan has ₹8080.97 Cr worth of assets under management (AUM) as of Mon May 05 2025. The latest Net Asset Value (NAV) of Nippon India Pharma Fund - Direct Plan - Bonus Plan as of Fri May 02 2025 is ₹548.7878. The fund has an expense ratio of 0.91%, which is medium comparable to most other Equity funds.
Nippon India Pharma Fund - Direct Plan - Bonus Plan returns for the last 1 year are 15.88%. Since launch, it has delivered 18.21% average annual returns.
The Nippon India Pharma Fund - Direct Plan - Bonus Plan has the majority of its money invested in Healthcare sectors.
Top 5 Holdings of Nippon India Pharma Fund - Direct Plan - Bonus Plan.
- Sun Pharmaceuticals Industries Ltd: 13.43%
- Divi's Laboratories Ltd: 9.28%
- Lupin Ltd: 7.27%
- Cipla Ltd: 5.71%
- Apollo Hospitals Enterprise Ltd: 5.31%
AMC Information
Name | Nippon Life India Asset Management Ltd |
---|---|
Founding Date | 2013-01-01 |
customercare@nipponindiaim.in | |
Phone | 022-6808 7000/18602660111 |
Website | https://mf.nipponindiaim.com/ |
Address | Nippon Life India Asset Management Limited,4th Floor, Tower A, Peninsula Business Park,,Ganapatrao Kadam Marg,,Lower Parel (W) |
Tax Implications of Nippon India Pharma Fund - Direct Plan - Bonus Plan
Short Term Gains | 20% + applicable Surcharge + 4% Cess |
---|---|
Long Term Gains | 12.5% without indexation + applicable Surcharge + 4% Cess |
Similar Funds from Nippon Life India Asset Management Ltd

AllocationAggressive Allocation
3Y CAGR
16.16%
expense ratio
1.11%
fund size
₹3687.73 Cr

EquityELSS (Tax Savings)
3Y CAGR
18.03%
expense ratio
1.04%
fund size
₹14392.25 Cr

EquityMulti-Cap
3Y CAGR
23.56%
expense ratio
0.77%
fund size
₹38636.66 Cr

AllocationEquity Savings
3Y CAGR
9.49%
expense ratio
0.74%
fund size
₹691.68 Cr

AllocationEquity Savings
3Y CAGR
8.50%
expense ratio
1.78%
fund size
₹691.68 Cr
FAQs
What is the current NAV of Nippon India Pharma Fund - Direct Plan - Bonus Plan?

What are the average returns of Nippon India Pharma Fund - Direct Plan - Bonus Plan?

How do I invest in Nippon India Pharma Fund - Direct Plan - Bonus Plan?

What is the expense ratio of Nippon India Pharma Fund - Direct Plan - Bonus Plan?

What are net assets under management (AUM) of Nippon India Pharma Fund - Direct Plan - Bonus Plan?

What is the PE and PB ratio of Nippon India Pharma Fund - Direct Plan - Bonus Plan?

What are the top 5 holdings of Nippon India Pharma Fund - Direct Plan - Bonus Plan?

What are the top 3 sectors that Nippon India Pharma Fund - Direct Plan - Bonus Plan has invested in?

Who is the manager of Nippon India Pharma Fund - Direct Plan - Bonus Plan?

What is the exit load of Nippon India Pharma Fund - Direct Plan - Bonus Plan?

How to Redeem Nippon India Pharma Fund - Direct Plan - Bonus Plan?

Can I invest in SIP and a Lump Sum of Nippon India Pharma Fund - Direct Plan - Bonus Plan?
